Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Yun Zhong's Stock Ratings
Wedbush Analyst
Yun Zhong is an analyst at Wedbush. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
16.0%
Smart Score
Overall Average Return Percentile
70th
Number of Ratings
65
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/12/2025 | WVE | Buy Now | WAVE Life Sciences | $16.59 | 98.92% | $20 → $33 | Maintains | Outperform | Get Alert | |
| 12/09/2025 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | 49.95% | → $32 | Initiates | → Outperform | Get Alert | |
| 11/18/2025 | ASND | Buy Now | Ascendis Pharma | $220.46 | -0.21% | $220 → $220 | Reiterates | Outperform → Outperform | Get Alert | |
| 11/11/2025 | WVE | Buy Now | WAVE Life Sciences | $16.59 | 20.55% | $18 → $20 | Maintains | Outperform | Get Alert | |
| 11/06/2025 | KROS | Buy Now | Keros Therapeutics | $20.89 | -23.41% | $15 → $16 | Maintains | Neutral | Get Alert | |
| 10/29/2025 | IRD | Buy Now | Opus Genetics | $2.29 | 249.34% | → $8 | Initiates | → Outperform | Get Alert | |
| 10/28/2025 | PTGX | Buy Now | Protagonist Therapeutics | $95.00 | -9.47% | $70 → $86 | Maintains | Outperform | Get Alert | |
| 09/30/2025 | MLTX | Buy Now | MoonLake | $14.49 | 24.22% | $80 → $18 | Maintains | Outperform | Get Alert | |
| 08/13/2025 | PASG | Buy Now | Passage Bio | $9.88 | 305.05% | $3 → $40 | Maintains | Outperform | Get Alert | |
| 08/11/2025 | SGMT | Buy Now | Sagimet Biosciences | $5.88 | 375.79% | → $28 | Initiates | → Outperform | Get Alert | |
| 08/08/2025 | ASND | Buy Now | Ascendis Pharma | $220.46 | -0.21% | $212 → $220 | Maintains | Outperform | Get Alert | |
| 08/07/2025 | VYGR | Buy Now | Voyager Therapeutics | $4.36 | 83.49% | $9 → $8 | Maintains | Outperform | Get Alert | |
| 06/23/2025 | WVE | Buy Now | WAVE Life Sciences | $16.59 | 8.5% | $18 → $18 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/30/2025 | KROS | Buy Now | Keros Therapeutics | $20.89 | -28.2% | $15 → $15 | Reiterates | Neutral → Neutral | Get Alert | |
| 05/27/2025 | CAMP | Buy Now | Camp4 Therapeutics | $6.29 | 27.19% | → $8 | Initiates | → Outperform | Get Alert | |
| 05/16/2025 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.48 | 820.86% | $32 → $32 | Reiterates | Outperform → Outperform | Get Alert | |
| 05/02/2025 | ASND | Buy Now | Ascendis Pharma | $220.46 | -3.84% | $181 → $212 | Maintains | Outperform | Get Alert | |
| 04/01/2025 | KROS | Buy Now | Keros Therapeutics | $20.89 | -28.2% | $15 → $15 | Reiterates | Neutral → Neutral | Get Alert | |
| 03/28/2025 | PTGX | Buy Now | Protagonist Therapeutics | $95.00 | -26.32% | $70 → $70 | Reiterates | Outperform → Outperform | Get Alert | |
| 03/12/2025 | VYGR | Buy Now | Voyager Therapeutics | $4.36 | — | — | Reiterates | Outperform → Outperform | Get Alert | |
| 11/29/2024 | PASG | Buy Now | Passage Bio | $9.88 | -59.5% | → $4 | Assumes | → Outperform | Get Alert | |
| 11/05/2024 | MLTX | Buy Now | MoonLake | $14.49 | 403.8% | $92 → $73 | Assumes | Outperform → Outperform | Get Alert | |
| 11/05/2024 | RZLT | Buy Now | Rezolute | $1.65 | 629.48% | → $12 | Initiates | → Outperform | Get Alert | |
| 11/05/2024 | PTGX | Buy Now | Protagonist Therapeutics | $95.00 | -38.95% | → $58 | Initiates | → Outperform | Get Alert | |
| 02/09/2023 | AVXL | Buy Now | Anavex Life Sciences | $4.18 | 569.86% | $35 → $28 | Maintains | Buy | Get Alert | |
| 02/02/2023 | TSHA | Buy Now | Taysha Gene Therapies | $5.82 | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 01/26/2023 | MGTA | Buy Now | Magenta Therapeutics | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 01/25/2023 | GRPH | Buy Now | Graphite Bio | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 01/18/2023 | FOLD | Buy Now | Amicus Therapeutics | $10.94 | 46.32% | $14 → $16 | Maintains | Buy | Get Alert | |
| 12/22/2022 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | 649.77% | $125 → $160 | Maintains | Buy | Get Alert | |
| 12/21/2022 | MGTA | Buy Now | Magenta Therapeutics | — | — | $6 → $3 | Maintains | Buy | Get Alert | |
| 12/08/2022 | AVRO | Buy Now | Avrobio | — | — | → $4 | Upgrade | Neutral → Buy | Get Alert | |
| 11/01/2022 | RCKT | Buy Now | Rocket Pharmaceuticals | $3.48 | 907.19% | → $35 | Initiates | → Buy | Get Alert | |
| 09/29/2022 | AGTC | Buy Now | Applied Genetic | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 09/21/2022 | RCOR | Buy Now | Renovacor | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 09/14/2022 | RCOR | Buy Now | Renovacor | — | — | → $8 | Initiates | → Buy | Get Alert | |
| 08/11/2022 | FRLN | Buy Now | Freeline Therapeutics | — | — | $10 → $5 | Maintains | Buy | Get Alert | |
| 04/18/2022 | MGTA | Buy Now | Magenta Therapeutics | — | — | $10 → $6 | Maintains | Buy | Get Alert | |
| 04/14/2022 | GRPH | Buy Now | Graphite Bio | — | — | → $18 | Initiates | → Buy | Get Alert | |
| 01/05/2022 | AVRO | Buy Now | Avrobio | — | — | — | Downgrade | Buy → Neutral | Get Alert | |
| 11/29/2021 | FRLN | Buy Now | Freeline Therapeutics | — | — | → $10 | Initiates | → Buy | Get Alert | |
| 10/12/2021 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | 485.75% | $110 → $125 | Maintains | Buy | Get Alert | |
| 09/23/2021 | AVXL | Buy Now | Anavex Life Sciences | $4.18 | 737.32% | → $35 | Initiates | → Buy | Get Alert | |
| 07/01/2021 | BLUE | Buy Now | bluebird bio | — | — | → $35 | Downgrade | Buy → Hold | Get Alert | |
| 06/15/2021 | QURE | Buy Now | uniQure | $20.01 | 129.89% | → $46 | Initiates | → Buy | Get Alert | |
| 06/15/2021 | SELB | Buy Now | Selecta Biosciences | — | — | → $10 | Initiates | → Buy | Get Alert | |
| 06/15/2021 | SIOX | Buy Now | Sio Gene Therapies | — | — | → $8 | Initiates | → Buy | Get Alert | |
| 06/15/2021 | PASG | Buy Now | Passage Bio | $9.88 | 153.15% | → $25 | Initiates | → Buy | Get Alert | |
| 06/15/2021 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | 415.46% | → $110 | Initiates | → Buy | Get Alert | |
| 06/15/2021 | MGTA | Buy Now | Magenta Therapeutics | — | — | → $20 | Initiates | → Buy | Get Alert | |
| 06/15/2021 | TSHA | Buy Now | Taysha Gene Therapies | $5.82 | 656.66% | → $44 | Initiates | → Buy | Get Alert | |
| 06/15/2021 | AGTC | Buy Now | Applied Genetic | — | — | → $11 | Initiates | → Buy | Get Alert | |
| 06/15/2021 | AVRO | Buy Now | Avrobio | — | — | → $23 | Initiates | → Buy | Get Alert | |
| 05/05/2021 | MREO | Buy Now | Mereo BioPharma Group | $2.17 | 359.77% | → $10 | Initiates | → Buy | Get Alert | |
| 11/11/2020 | BLUE | Buy Now | bluebird bio | — | — | → $64 | Initiates | → Buy | Get Alert | |
| 12/13/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | 720.06% | $160 → $175 | Maintains | Buy | Get Alert | |
| 12/06/2019 | MGTA | Buy Now | Magenta Therapeutics | — | — | — | Initiates | → Buy | Get Alert | |
| 08/20/2019 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | 720.06% | $200 → $175 | Maintains | Buy | Get Alert | |
| 08/22/2018 | NITE | Buy Now | Nightstar Therapeutics | $34.88 | -2.52% | → $34 | Initiates | → Buy | Get Alert | |
| 06/15/2018 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | 462.32% | → $120 | Initiates | → Buy | Get Alert | |
| 01/04/2018 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | 251.45% | → $75 | Initiates | → Buy | Get Alert | |
| 09/19/2016 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | — | — | Upgrade | Neutral → Buy | Get Alert | |
| 04/20/2016 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | — | — | Initiates | → Neutral | Get Alert | |
| 11/12/2013 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | -53.14% | $34 → $10 | Downgrade | Neutral → Sell | Get Alert | |
| 04/16/2013 | SRPT | Buy Now | Sarepta Therapeutics | $21.34 | 59.33% | → $34 | Downgrade | Buy → Neutral | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved